{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:02:14Z","timestamp":1790643734158,"version":"4.1.0"},"posted":{"date-parts":[[2026,9,29]]},"group-title":"In Review","reference-count":34,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,31]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background<\/bold>\n                  Human papillomavirus (HPV) is the primary cause of cervical cancer, with women living with HIV at increased risk of HPV infection and HPV-related disease. Data on HPV prevalence and genotype distribution among adolescent girls and young women (AGYW) in rural South African settings remain limited. We estimated HPV prevalence, genotype distribution, and factors associated with HPV infection among AGYW in a high HIV prevalence district of KwaZulu-Natal, South Africa.\n                  <bold>Methods<\/bold>\n                  This cross-sectional study was nested within the baseline survey of the Thetha Nami population-based trial among young people aged 15\u201330 years in rural uMkhanyakude District, KwaZulu-Natal.  Survey participants were asked to provide dried blood spots for HIV testing and genital swabs for STI testing. For this study, we selected AGYW living with HIV with available vaginal swabs and a frequency-matched sample of AGYW without HIV. HPV genotyping was done using the HPV Direct Flow Chip Kit (Master Diagnostica, Spain). Genotype-specific HPV prevalence was described overall and by HIV status. Logistic regression was used to identify factors associated with HPV infection.\n                  <bold>Results<\/bold>\n                  Among 187 AGYW with valid HPV results, 90 (48.1%) were living with HIV. Overall HPV prevalence was 69.1% (95% confidence interval (CI)\u2009=\u200954.5\u201380.7%) and high-risk (hr)HPV prevalence was 57.3% (95%CI\u2009=\u200944.1\u201369.6%). HPV prevalence was higher among AGYW living with HIV than among AGYW without HIV (84.6% vs 64.6%, p\u2009=\u20090.02). HPV genotype distribution varied by HIV status: HPV35, HPV45 and HPV58 were the most prevalent hrHPV genotypes among AGYW living with HIV, vs HPV52, HPV56 and HPV31 among AGYW without HIV. No HPV16 or HPV18 infections were detected among participants who were age-eligible for the national HPV vaccination programme. Reported condomless sex (adjusted odds ratio (1) 2.23, 95%CI\u2009=\u20091.06\u20134.70) and the presence of another sexually transmitted infection (aOR\u2009=\u20094.30, 95%CI\u2009=\u20091.52\u201312.20) were associated with HPV infection.\n                  <bold>Conclusions<\/bold>\n                  AGYW in rural uMkhanyakude experience a high burden of hrHPV infection, especially those living with HIV. Regardless of HPV vaccination status not being confirmed, no HPV 16\/18 was detected among vaccine-eligible AGYW. The higher prevalence of non-HPV16\/18 hrHPV genotypes covered by the nonavalent vaccine highlights the potential value of vaccines with broader genotype coverage. These findings support expanding HPV screening and cervical cancer prevention programmes in high HIV prevalence settings.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10548481\/v1","type":"posted-content","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:40:37Z","timestamp":1790642437000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and genotype distribution of human papillomavirus (HPV) among adolescent girls and young women in a high HIV burden rural area of South Africa: a cross-sectional survey"],"prefix":"10.21203","author":[{"given":"Maphe","family":"Mthembu","sequence":"first","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Baisley","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Busang","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nqobile","family":"Ngoma","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonsikelelo","family":"Ndlela","sequence":"additional","affiliation":[{"name":"Centre for the AIDS Programme of Research in South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonhlanhla","family":"Okesola","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Herbst","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thandeka","family":"Khoza","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaco","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenine","family":"Liebenberg","sequence":"additional","affiliation":[{"name":"Stellenbosch University, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaza","family":"Ndhlovu","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shahmanesh","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-020-19412-6","article-title":"Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis","volume":"11","author":"Moreira-Teixeira L","year":"2020","unstructured":"Moreira-Teixeira L, Stimpson PJ, Stavropoulos E, Hadebe S, Chakravarty P, Ioannou M, et al. Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat Commun. 2020;11(1):5566.","journal-title":"Nat Commun"},{"key":"ref2","volume-title":"Cancer in South Africa: Full Report","author":"Registry NC","year":"2024","unstructured":"Registry NC. Cancer in South Africa: Full Report. Division of National Health Laboratory Services; 2024."},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"Martel C","year":"2017","unstructured":"de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370.","journal-title":"Int J Cancer"},{"key":"ref4","unstructured":"WHO. Human papillomavirus and cancer. 2024."},{"key":"ref5","volume-title":"Cervical cancer: 19 of the top 20 countries with the highest cervical cancer cases were in sub-Saharan Africa in 2018","author":"Region WHO-A","year":"2022","unstructured":"Region WHO-A. Cervical cancer: 19 of the top 20 countries with the highest cervical cancer cases were in sub-Saharan Africa in 2018. World Health Organization-African Region; 2022."},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"e0146603","DOI":"10.1371\/journal.pone.0146603","article-title":"High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa","volume":"11","author":"Ebrahim S","year":"2016","unstructured":"Ebrahim S, Mndende XK, Kharsany ABM, Mbulawa ZZA, Naranbhai V, Frohlich J, et al. High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa. PLoS ONE. 2016;11(1):e0146603.","journal-title":"PLoS ONE"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/23744235.2017.1312513","article-title":"High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination","volume":"49","author":"Mbatha JN","year":"2017","unstructured":"Mbatha JN, Taylor M, Kleppa E, Lillebo K, Galapaththi-Arachchige HN, Singh D, et al. High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination. Infect Dis. 2017;49(8):601\u20138.","journal-title":"Infect Dis"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"e0294698","DOI":"10.1371\/journal.pone.0294698","article-title":"High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV","volume":"18","author":"Qulu W","year":"2023","unstructured":"Qulu W, Mtshali A, Osman F, Ndlela N, Ntuli L, Mzobe G, et al. High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV. PLoS ONE. 2023;18(11):e0294698.","journal-title":"PLoS ONE"},{"issue":"8","key":"ref9","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/pathogens12081032","article-title":"Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis","volume":"12","author":"Tchouaket MCT","year":"2023","unstructured":"Tchouaket MCT, Ka\u2019e AC, Semengue ENJ, Sosso SM, Simo RK, Yagai B, et al. Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Pathogens. 2023;12(8):1032.","journal-title":"Pathogens"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/23744235.2017.1312513","article-title":"High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination","volume":"49","author":"Mbatha JN","year":"2017","unstructured":"Mbatha JN, Myra T, Elisabeth K, Kristine L, Deepak NG-AH. High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination. Infect Dis. 2017;49(8):601\u20138.","journal-title":"Infect Dis"},{"issue":"3","key":"ref11","first-page":"433","article-title":"Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa","volume":"21","author":"Firnhaber C","year":"2010","unstructured":"Firnhaber C, Van Le H, Pettifor A, Schulze D, Michelow P, Sanne IM, et al. Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control. 2010;21(3):433\u201343.","journal-title":"Cancer Causes Control"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu G","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. Aids. 2018;32(6):795\u2013808.","journal-title":"Aids"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/1471-0528.16758","article-title":"Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study","volume":"128","author":"Luckett R","year":"2021","unstructured":"Luckett R, Painter H, Hacker MR, Simon B, Seiphetlheng A, Erlinger A, et al. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study. BJOG. 2021;128(12):1986\u201396.","journal-title":"BJOG"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12885-024-11928-0","article-title":"Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda","volume":"24","author":"Nakigozi H","year":"2024","unstructured":"Nakigozi H, Ndejjo R, Bazeyo W, Nabaggala A, Achola C, Iga M, et al. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda. BMC Cancer. 2024;24(1):243.","journal-title":"BMC Cancer"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1016\/S2214-109X(21)00176-5","article-title":"Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study","volume":"9","author":"Wong EB","year":"2021","unstructured":"Wong EB, Olivier S, Gunda R, Koole O, Surujdeen A, Gareta D, et al. Convergence of infectious and non-communicable disease epidemics in rural South Africa: a cross-sectional, population-based multimorbidity study. Lancet Global Health. 2021;9(7):e967\u201376.","journal-title":"Lancet Global Health"},{"key":"ref16","author":"Adler D","year":"2008","unstructured":"Adler D, Bruyn Guy d, Laher F, Gray G, Allan Bruce R, Williamson A-L. Human Papillomavirus Genotype Distribution among Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Women in Soweto, South Africa. Journal of Clinical Microbiology. 2008;46(12):4109\u201310."},{"key":"ref17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12879-015-1181-8","article-title":"Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status","volume":"15","author":"Mbulawa ZZ","year":"2015","unstructured":"Mbulawa ZZ, Coetzee D, Williamson AL. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis. 2015;15:459.","journal-title":"BMC Infect Dis"},{"key":"ref18","unstructured":"Africa RoS. Human Papilloma Virus Vaccination Campaign. South African Government Communications. 2014."},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.9745\/GHSP-D-18-00090","article-title":"Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign","volume":"6","author":"Delany-Moretlwe S","year":"2018","unstructured":"Delany-Moretlwe S, Kelley KF, James S, Scorgie F, Subedar H, Dlamini NR, et al. Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign. Glob Health Sci Pract. 2018;6(3):425\u201338.","journal-title":"Glob Health Sci Pract"},{"key":"ref20","first-page":"10","article-title":"Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?","author":"Amponsah-Dacosta E","year":"2022","unstructured":"Amponsah-Dacosta E, Blose N, Nkwinika VV, Chepkurui V. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services? Front Public Health. 2022;Volume 10\u20132022.","journal-title":"Front Public Health"},{"key":"ref21","volume-title":"District Health Barometer 2023\/24: Non-communicable diseases chapter","author":"Trust HS","year":"2024","unstructured":"Trust HS. District Health Barometer 2023\/24: Non-communicable diseases chapter. Durban: Health Systems Trust; 2024."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1634\/theoncologist.2017-0444","article-title":"Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus\u2010Positive Women and Health Care Practitioners in Tanzania","volume":"24","author":"Bateman LB","year":"2018","unstructured":"Bateman LB, Blakemore S, Koneru A, Mtesigwa T, McCree R, Lisovicz NF, et al. Barriers and Facilitators to Cervical Cancer Screening, Diagnosis, Follow-Up Care and Treatment: Perspectives of Human Immunodeficiency Virus\u2010Positive Women and Health Care Practitioners in Tanzania. Oncologist. 2018;24(1):69\u201375.","journal-title":"Oncologist"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"e0001826","DOI":"10.1371\/journal.pgph.0001826","article-title":"A qualitative study to explore healthcare providers\u2019 perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa","volume":"3","author":"Tshabalala G","year":"2023","unstructured":"Tshabalala G, Blanchard C, Mmoledi K, Malope D, O\u2019Neil DS, Norris SA, et al. A qualitative study to explore healthcare providers\u2019 perspectives on barriers and enablers to early detection of breast and cervical cancers among women attending primary healthcare clinics in Johannesburg, South Africa. PLOS Global Public Health. 2023;3(5):e0001826.","journal-title":"PLOS Global Public Health"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1186\/s12889-023-16262-x","article-title":"Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa","volume":"23","author":"Busang J","year":"2023","unstructured":"Busang J, Zuma T, Herbst C, Okesola N, Chimbindi N, Dreyer J, et al. Thetha Nami ngithethe nawe (Let's Talk): a stepped-wedge cluster randomised trial of social mobilisation by peer navigators into community-based sexual health and HIV care, including pre-exposure prophylaxis (PrEP), to reduce sexually transmissible HIV amongst young people in rural KwaZulu-Natal, South Africa. BMC Public Health. 2023;23(1):1553.","journal-title":"BMC Public Health"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1473-3099(12)70187-1","article-title":"Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis","volume":"12","author":"Malag\u00f3n T","year":"2012","unstructured":"Malag\u00f3n T, Drolet M, Boily M-C, Franco EL, Jit M, Brisson J, et al. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(10):781\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"e0264498","DOI":"10.1371\/journal.pone.0264498","article-title":"High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention","volume":"17","author":"Mbulawa ZZA","year":"2022","unstructured":"Mbulawa ZZA, Phohlo K, Garcia-Jardon M, Williamson A-L, Businge CB. High human papillomavirus (HPV)-35 prevalence among South African women with cervical intraepithelial neoplasia warrants attention. PLoS ONE. 2022;17(3):e0264498.","journal-title":"PLoS ONE"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S2352-3018(17)30149-2","article-title":"Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis","volume":"5","author":"Kelly H","year":"2018","unstructured":"Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis. Lancet HIV. 2018;5(1):e45\u201358.","journal-title":"Lancet HIV"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/cix135","article-title":"Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer","volume":"64","author":"Clifford GM","year":"2017","unstructured":"Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis. 2017;64(9):1228\u201335.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(25)00525-X","article-title":"Population impact of South Africa's human papillomavirus (HPV) vaccination programme on HPV prevalence in adolescent girls with and without HIV: a repeat cross-sectional study","volume":"14","author":"Machalek DA","year":"2026","unstructured":"Machalek DA, Nyemba DC, Travill D, Petoumenos K, Mbulawa ZZA, Naidoo I, et al. Population impact of South Africa's human papillomavirus (HPV) vaccination programme on HPV prevalence in adolescent girls with and without HIV: a repeat cross-sectional study. Lancet Global Health. 2026;14(4):e570\u20138.","journal-title":"Lancet Global Health"},{"issue":"2","key":"ref30","first-page":"e103298","article-title":"High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, Nigeria","volume":"18","author":"Cosmas NT","year":"2026","unstructured":"Cosmas NT, Magaji FA, Acheng SY, Lauya L, Okolo MO, Christian EN, et al. High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, Nigeria. Cureus. 2026;18(2):e103298.","journal-title":"Cureus"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"e0253074","DOI":"10.1371\/journal.pone.0253074","article-title":"High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa","volume":"16","author":"Mbulawa ZZA","year":"2021","unstructured":"Mbulawa ZZA, Somdyala NI, Mabunda SA, Williamson A-L. High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa. PLoS ONE. 2021;16(6):e0253074.","journal-title":"PLoS ONE"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100898","DOI":"10.1016\/j.clinsp.2026.100898","article-title":"Self-collected versus clinician-collected samples for HPV testing: A meta-analysis revealing lower sensitivity for detecting high-grade cervical lesions","volume":"81","author":"Lima GGS","year":"2026","unstructured":"Lima GGS, Costa AS, Alves MS, Turri JAO, Zuchelo LTS, Lorenzi NPC, et al. Self-collected versus clinician-collected samples for HPV testing: A meta-analysis revealing lower sensitivity for detecting high-grade cervical lesions. Clinics. 2026;81:100898.","journal-title":"Clinics"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"e001351","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh PT","year":"2019","unstructured":"Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019;4(3):e001351.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s44370-025-00019-8","article-title":"Novel therapeutic vaccine development strategies targeting high risk HPV16\/18-E6\/7 oncoproteins, their immunogenicity, and efficacy associated with cervical intraepithelial neoplasia and cervical cancer: a systematic review","volume":"2","author":"Teffera ZH","year":"2025","unstructured":"Teffera ZH, Abebaw D, Akelew Y, Belayneh M, Mesganaw Shitie B, Selabat B, et al. Novel therapeutic vaccine development strategies targeting high risk HPV16\/18-E6\/7 oncoproteins, their immunogenicity, and efficacy associated with cervical intraepithelial neoplasia and cervical cancer: a systematic review. Discover Viruses. 2025;2(1):14.","journal-title":"Discover Viruses"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10548481\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10548481\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:41:03Z","timestamp":1790642463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10548481\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":34,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10548481\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,9,29]]},"subtype":"preprint"}}